Invion (ASX:IVX) YoY EBITDA Growth : -340.00% (As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Invion YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Invion's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was -340.00%.

Invion's EBITDA per Share for the six months ended in Dec. 2024 was A$-0.02.

Invion YoY EBITDA Growth Historical Data

The historical data trend for Invion's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invion YoY EBITDA Growth Chart

Invion Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

YoY EBITDA Growth

Get a 7-Day Free Trial

65.00

-64.29

-34.78

51.61

-373.33

Invion Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
YoY EBITDA Growth	Get a 7-Day Free Trial															52.94	53.33	37.50	-842.86	-340.00

Invion YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Invion's YoY EBITDA Growth for the fiscal year that ended in Jun. 2024 is calculated as:

	YoY EBITDA Growth (A: Jun. 2024 )
=	(EBITDA per Share (A: Jun. 2024 )	-	EBITDA per Share (A: Jun. 2023 ))	/	\| EBITDA per Share (A: Jun. 2023 ) \|
=	(-0.071	-	-0.015)	/	\| -0.015 \|
=	-373.33 %

Invion's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2024 )
=	(EBITDA per Share (Q: Dec. 2024 )	-	EBITDA per Share (Q: Dec. 2023 ))	/	\| EBITDA per Share (Q: Dec. 2023 )) \|
=	(-0.022	-	-0.005)	/	\| -0.005 \|
=	-340.00 %

Invion YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Invion's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Invion Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invion Ltd (ASX:IVX) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

IVIXF:USA 7C8:Germany

Address

692 High Street, East Kew, VIC, AUS, 3102

Website

https://www.inviongroup.com

Invion Ltd is an Australian clinical-stage pharmaceutical drug development company. It is engaged in the development of PhotoDynamic Therapy (PDT) for cancer treatments called Photosoft, for the treatment of a range of cancers and infectious diseases. The company produces topical and intravenous products suitable for use in skin cancer and solid tumors, such as ovarian, prostate, and lung cancer. Invion has developed a portfolio of patent protected compounds. Its drug candidate is INV043, a novel photosensitiser which has the potential to work as a therapy and a diagnostic tool.

Invion Headlines

No Headlines